Aspiriant LLC Has $2.62 Million Holdings in Oracle Co. (NYSE:ORCL)

Aspiriant LLC lessened its holdings in shares of Oracle Co. (NYSE:ORCL) by 5.3% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 20,866 shares of the enterprise software provider’s stock after selling 1,159 shares during the period. Aspiriant LLC’s holdings in Oracle were worth $2,621,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of the business. Norges Bank acquired a new position in Oracle in the fourth quarter valued at $1,210,181,000. Wellington Management Group LLP raised its holdings in shares of Oracle by 9,299.3% during the third quarter. Wellington Management Group LLP now owns 8,170,999 shares of the enterprise software provider’s stock valued at $865,472,000 after purchasing an additional 8,084,067 shares during the period. Vanguard Group Inc. raised its holdings in shares of Oracle by 5.7% during the third quarter. Vanguard Group Inc. now owns 147,273,413 shares of the enterprise software provider’s stock valued at $15,599,200,000 after purchasing an additional 7,883,515 shares during the period. Boston Partners raised its holdings in shares of Oracle by 382.4% during the fourth quarter. Boston Partners now owns 4,563,366 shares of the enterprise software provider’s stock valued at $481,820,000 after purchasing an additional 3,617,413 shares during the period. Finally, Capital World Investors raised its holdings in shares of Oracle by 22.1% during the fourth quarter. Capital World Investors now owns 18,384,162 shares of the enterprise software provider’s stock valued at $1,938,242,000 after purchasing an additional 3,323,334 shares during the period. Institutional investors and hedge funds own 42.44% of the company’s stock.

Insider Activity at Oracle

In related news, insider Edward Screven sold 235,918 shares of the company’s stock in a transaction that occurred on Thursday, June 20th. The shares were sold at an average price of $144.30, for a total transaction of $34,042,967.40. Following the sale, the insider now directly owns 2,626,764 shares in the company, valued at approximately $379,042,045.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Oracle news, Director Jeffrey Berg sold 22,500 shares of the stock in a transaction that occurred on Thursday, June 20th. The shares were sold at an average price of $143.12, for a total value of $3,220,200.00. Following the sale, the director now directly owns 210,712 shares in the company, valued at approximately $30,157,101.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Edward Screven sold 235,918 shares of the stock in a transaction that occurred on Thursday, June 20th. The stock was sold at an average price of $144.30, for a total transaction of $34,042,967.40. Following the completion of the sale, the insider now owns 2,626,764 shares in the company, valued at $379,042,045.20. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 348,418 shares of company stock worth $47,784,717. 42.80% of the stock is owned by corporate insiders.

Oracle Stock Down 0.7 %

ORCL opened at $138.25 on Thursday. The company has a quick ratio of 0.72, a current ratio of 0.71 and a debt-to-equity ratio of 8.25. The stock has a market cap of $381.00 billion, a price-to-earnings ratio of 37.26, a PEG ratio of 2.52 and a beta of 1.01. Oracle Co. has a twelve month low of $99.26 and a twelve month high of $145.32. The company’s 50-day moving average price is $123.84 and its two-hundred day moving average price is $117.48.

Oracle (NYSE:ORCL) last announced its quarterly earnings results on Tuesday, June 11th. The enterprise software provider reported $1.63 EPS for the quarter, missing analysts’ consensus estimates of $1.65 by ($0.02). The business had revenue of $14.29 billion for the quarter, compared to analysts’ expectations of $14.57 billion. Oracle had a net margin of 19.76% and a return on equity of 223.01%. The business’s quarterly revenue was up 3.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.35 earnings per share. As a group, equities analysts expect that Oracle Co. will post 5.01 earnings per share for the current year.

Oracle Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 25th. Investors of record on Thursday, July 11th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.16%. The ex-dividend date is Thursday, July 11th. Oracle’s payout ratio is currently 43.13%.

Wall Street Analyst Weigh In

ORCL has been the topic of several research reports. Mizuho upped their price objective on shares of Oracle from $160.00 to $170.00 and gave the company a “buy” rating in a report on Monday, June 17th. UBS Group boosted their target price on shares of Oracle from $150.00 to $160.00 and gave the stock a “buy” rating in a research report on Wednesday, June 12th. KeyCorp boosted their target price on shares of Oracle from $150.00 to $165.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 12th. The Goldman Sachs Group boosted their target price on shares of Oracle from $115.00 to $130.00 and gave the stock a “neutral” rating in a research report on Wednesday, March 13th. Finally, Argus boosted their target price on shares of Oracle from $145.00 to $159.00 and gave the stock a “buy” rating in a research report on Tuesday, June 18th. Fourteen investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $145.83.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.